Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 171-180 of 304 for heart disease

Edit search filters
  1. EKO Duo Device in Patients with Genetic Heart Diseases

    Rochester, MN

  2. Stress Echocardiography in Mixed and Multi Valvular Heart Disease

    Rochester, MN

  3. Aortic Valve Operative Outcomes in Marfan Patients

    Rochester, MN

  4. Mobile Monitoring of Children with Single Ventricle Congenital Heart Disease

    Rochester, MN

  5. Gene Polymorphisms in Cardiovascular Health and Disease

    Rochester, MN

  6. A Noninvasive Monitor for the Detection of Preclinical Heart Failure in Children with Congenital or Acquired Heart Disease

    Rochester, MN

  7. Registry for Mayo Clinic Adult Congenital Heart Disease Control Population

    Rochester, MN

  8. A Study to Evaluate Brain Natriuretic Peptides for the Avoidance of Treatment-Related Heart Failure in Breast Cancer Survivors

    Rochester, MN

  9. Registry of Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Congenital Heart Disease

    Rochester, MN

  10. A Study of Ultrasound Shear Wave Elastography to Assess Heart Muscle Stiffness for Patients with Diastolic Heart Failure

    Rochester, MN

.

Mayo Clinic Footer